Search Results - "Paull, Jeremy"

Refine Results
  1. 1
  2. 2
  3. 3

    Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial by Castellarnau, Alex, Heery, Graham P., Seta, Aynaz, Luscombe, Carolyn A., Kinghorn, George R., Button, Peter, McCloud, Philip, Paull, Jeremy R. A.

    Published in Scientific reports (17-06-2022)
    “…Astodrimer sodium is a dendrimer molecule with antiviral and virucidal activity against SARS-CoV-2 and other respiratory viruses in vitro, and has previously…”
    Get full text
    Journal Article
  4. 4

    SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans by Price, Clare F, Tyssen, David, Sonza, Secondo, Davie, Ashley, Evans, Sonya, Lewis, Gareth R, Xia, Shirley, Spelman, Tim, Hodsman, Peter, Moench, Thomas R, Humberstone, Andrew, Paull, Jeremy R A, Tachedjian, Gilda

    Published in PloS one (15-09-2011)
    “…SPL7013 Gel (VivaGel(®)) is a microbicide in development for prevention of HIV and HSV. This clinical study assessed retention and duration of antiviral…”
    Get full text
    Journal Article
  5. 5

    Astodrimer sodium nasal spray forms a barrier to SARS-CoV-2 in vitro and preserves normal mucociliary function in human nasal epithelium by Paull, Jeremy R. A., Luscombe, Carolyn A., Seta, Aynaz, Heery, Graham P., Bobardt, Michael D., Gallay, Philippe A., Constant, Samuel, Castellarnau, Alex

    Published in Scientific reports (11-09-2024)
    “…COVID-19 remains a severe condition for many including immunocompromised individuals. There remains a need for effective measures against this and other…”
    Get full text
    Journal Article
  6. 6

    A phase I randomized placebo controlled trial of the safety of 3% SPL7013 Gel (VivaGel®) in healthy young women administered twice daily for 14 days by Cohen, Craig R, Brown, Joelle, Moscicki, Anna-Barbara, Bukusi, Elizabeth A, Paull, Jeremy R A, Price, Clare F, Shiboski, Stephen

    Published in PloS one (20-01-2011)
    “…To assess the safety of VivaGel® used vaginally twice daily for 14 days among healthy, sexually-abstinent women, aged 18-24 years in the USA and Kenya…”
    Get full text
    Journal Article
  7. 7

    Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1 by Telwatte, Sushama, Moore, Katie, Johnson, Adam, Tyssen, David, Sterjovski, Jasminka, Aldunate, Muriel, Gorry, Paul R., Ramsland, Paul A., Lewis, Gareth R., Paull, Jeremy R.A., Sonza, Secondo, Tachedjian, Gilda

    Published in Antiviral research (01-06-2011)
    “…Topical microbicides for use by women to prevent the transmission of human immunodeficiency virus (HIV) and other sexually transmitted infections are urgently…”
    Get full text
    Journal Article
  8. 8

    Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro by Paull, Jeremy R.A., Heery, Graham P., Bobardt, Michael D., Castellarnau, Alex, Luscombe, Carolyn A., Fairley, Jacinth K., Gallay, Philippe A.

    Published in Antiviral research (01-07-2021)
    “…An effective response to the ongoing coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) will…”
    Get full text
    Journal Article
  9. 9

    Topical Astodrimer Sodium, a Non-Toxic Polyanionic Dendrimer, Demonstrates Antiviral Activity in an Experimental Ocular Adenovirus Infection Model by Romanowski, Eric G, Yates, Kathleen A, Paull, Jeremy R A, Heery, Graham P, Shanks, Robert M Q

    Published in Molecules (Basel, Switzerland) (05-06-2021)
    “…There is no approved antiviral therapy for adenovirus (HAdV) ocular infections. Astodrimer sodium (SPL7013) is a polyanionic dendrimer with antiviral activity…”
    Get full text
    Journal Article
  10. 10

    Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice by Paull, Jeremy R. A., Luscombe, Carolyn A., Castellarnau, Alex, Heery, Graham P., Bobardt, Michael D., Gallay, Philippe A.

    Published in Viruses (20-08-2021)
    “…Strategies to combat COVID-19 require multiple ways to protect vulnerable people from infection. SARS-CoV-2 is an airborne pathogen and the nasal cavity is a…”
    Get full text
    Journal Article
  11. 11

    Safety, Tolerability, and Pharmacokinetics of SPL7013 Gel (VivaGel®): A Dose Ranging, Phase I Study by O'Loughlin, John, Millwood, Iona Y., McDonald, Helen M., Price, Clare F., Kaldor, John M., Paull, Jeremy R. A.

    Published in Sexually transmitted diseases (01-02-2010)
    “…Objectives: To evaluate safety, tolerability and systemic pharmacokinetics of escalating doses of SPL7013 Gel in healthy women. Design: Randomized,…”
    Get full text
    Journal Article
  12. 12

    Astodrimer Sodium Nasal Spray versus Placebo in Non-Hospitalised Patients with COVID-19: A Randomised, Double-Blinded, Placebo-Controlled Trial by Winchester, Stephen, Castellarnau, Alex, Jabbar, Kashif, Nadir, Meera, Ranasinghe, Kapila, Masramon, Xavier, Kinghorn, George R, John, Isaac, Paull, Jeremy R A

    Published in Pharmaceutics (06-09-2024)
    “…Dendrimer-based astodrimer sodium nasal spray was assessed for its ability to reduce SARS-CoV-2 load in outpatients with COVID-19, which remains a severe…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Dendrimers as Drugs:  Discovery and Preclinical and Clinical Development of Dendrimer-Based Microbicides for HIV and STI Prevention by McCarthy, Tom D., Karellas, Peter, Henderson, Scott A., Giannis, Michael, O'Keefe, David F., Heery, Graham, Paull, Jeremy R. A., Matthews, Barry R., Holan, George

    Published in Molecular pharmaceutics (01-07-2005)
    “…Starpharma focuses on the use of dendrimers as drugs in their own right, in contrast to dendrimers as drug delivery vehicles or diagnostics. This contextual…”
    Get full text
    Journal Article
  15. 15

    A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis by Schwebke, Jane R., Carter, Belvia A., Waldbaum, Arthur S., Agnew, Kathy J., Paull, Jeremy R.A., Price, Clare F., Castellarnau, Alex, McCloud, Philip, Kinghorn, George R.

    “…•Recurrent bacterial vaginosis impacts on women and carries a high financial burden.•Astodrimer 1% Gel was superior to placebo for prevention of recurrent…”
    Get full text
    Journal Article
  16. 16

    Enhancement of Human Immunodeficiency Virus Type 1 Replication Is Not Intrinsic to All Polyanion-Based Microbicides by SONZA, Secondo, JOHNSON, Adam, TYSSEN, David, SPELMAN, Tim, LEWIS, Gareth R, PAULL, Jeremy R. A, TACHEDJIAN, Gilda

    Published in Antimicrobial Agents and Chemotherapy (01-08-2009)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Formulating a Sulfonated Antiviral Dendrimer in a Vaginal Microbicidal Gel Having Dual Mechanisms of Action by Mumper, Russell J., Bell, Michael A., Worthen, David R., Cone, Richard A., Lewis, Gareth R., Paull, Jeremy R. A., Moench, Thomas R.

    Published in Drug development and industrial pharmacy (01-05-2009)
    “…SPL7013 is the sodium salt of a sulfonated dendrimer that has potent antiviral properties. VivaGel®, a topical gel containing 3% (wt wt) SPL7013, is in…”
    Get full text
    Journal Article
  19. 19

    Restraint Stress: Differential Cardiovascular Responses in Wistar-Kyoto and Spontaneously Hypertensive Rats by McDougall, Stuart J, Paull, Jeremy R. A, Widdop, Robert E, Lawrence, Andrew J

    Published in Hypertension (Dallas, Tex. 1979) (01-01-2000)
    “…With the use of a restraint stress paradigm, both normotensive Wistar-Kyoto (WKY ) rats and spontaneously hypertensive rats (SHR) underwent acute (1-hour…”
    Get full text
    Journal Article
  20. 20

    A Randomized Controlled Trial of the Safety of Candidate Microbicide SPL7013 Gel When Applied to the Penis by Chen, Marcus Y, Millwood, Iona Y, Wand, Handan, Poynten, Mary, Law, Matthew, Kaldor, John M, Wesselingh, Steve, Price, Clare F, Clark, Laura J, Paull, Jeremy R A, Fairley, Christopher K

    “…OBJECTIVES:To determine the safety of the candidate vaginal microbicide SPL7013 gel (VivaGel) when applied to the penis. METHODS:A randomized, double-blind,…”
    Get full text
    Journal Article